#United States #Arlington #American Diabetes Association #Rita Kalyani #Joshua Neumiller

Major Transition at the American Diabetes Association

On October 21, 2026, the American Diabetes Association (ADA) formally announced an important transition in its leadership. Dr. Rita Kalyani, who served as the Chief Scientific and Medical Officer, has departed from her role effective immediately. This change incites a new chapter for the ADA, a pivotal organization in the fight against diabetes in America.

A Change in Leadership

In the wake of Dr. Kalyani's departure, the ADA has entrusted Joshua Neumiller, PharmD, CDCES, FADCES, FASCP, with expanded responsibilities. He already held the position of Senior Vice President of Medical Affairs and will now oversee the ADA's scientific and medical approaches during this pivotal transitional phase. The organization is embarking on a thorough search for a permanent Chief Scientific and Medical Officer, ensuring it continues to uphold its mission and commitment to the diabetes community.

Dr. Neumiller’s extensive background in diabetes management and experience with the ADA render him a qualified individual to guide the organization through this significant change. His role will ensure continuity in key programs, which include the ADA's essential Standards of Care in Diabetes and the Scientific Sessions that bring together the best minds in diabetes research.

Commitment to the Diabetes Community

Charles "Chuck" Henderson, the ADA’s CEO, expressed gratitude towards Dr. Kalyani for her unwavering dedication over the years. Henderson noted, “The researchers and healthcare professionals who make up our science and medicine community are the foundation of everything the ADA does.” This statement highlights the ADA’s deep-rooted commitment to advancing diabetes research and care, which is more crucial than ever as the prevalence of diabetes continues to rise in the United States.

The ADA is engaging with its scientific and medical community throughout this leadership search, looking to define the future priorities and qualifications that they seek in their next leader. This inclusive approach emphasizes the role of collaboration and shared vision in advancing diabetes care and treatment.

About the American Diabetes Association

For over 86 years, the American Diabetes Association has stood at the forefront of fighting diabetes. It is the leading voluntary health organization dedicated to preventing and curing diabetes while improving the lives of those affected by this condition. With an objective to educate and drive research, the ADA focuses on enhancing the lives of more than 155 million Americans living with diabetes or prediabetes.

In the face of challenges such as soaring diabetes rates, the ADA's advocacy efforts continue to push for better treatment options, increased funding for research, and greater awareness around this persistent health epidemic. Their commitment transcends mere statistics; they aim to transform lives through comprehensive education, robust research facilitation, and community engagement.

Looking Ahead

As the ADA moves into a new phase under temporary leadership, it remains dedicated to its mission. The organization recognizes the need for innovation and adaptive strategies to tackle the evolving landscape of diabetes management. ADA’s members and supporters are encouraged to remain engaged as this transition unfolds, demonstrating resilience and a collective commitment to ending the diabetes epidemic. Join the fight against diabetes and support the ADA's mission by visiting diabetes.org or by following them on social media platforms.

This leadership change, while challenging, opens the door to fresh ideas and potential developments in diabetes care and research. As the ADA continues its pivotal work, the importance of leadership that echoes its foundational mission will guide progress in the fight against this significant public health concern.